E. Demant

发表

Binding of transferrin‐iron by adriamycin at acidic pH

N. nørskov-lauritsen, E. Demant, Niels Nørskov-Lauritsen, 1986, FEBS letters.

Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.

M. Sehested, P. B. Jensen, N. Bindslev, 1989, Biochemical pharmacology.

Lipid Rafts Exist as Stable Cholesterol-independent Microdomains in the Brush Border Membrane of Enterocytes*

L. Niels-Christiansen, G. Hansen, E. Danielsen, 2001, The Journal of Biological Chemistry.

Stopped-flow kinetic analysis of long-chain fatty acid dissociation from bovine serum albumin.

A. Kleinfeld, E. Demant, G. V. Richieri, 2002, The Biochemical journal.

A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells.

M. Sehested, P. B. Jensen, E. Demant, 1990, Biochimica et biophysica acta.

Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments.

H. Hansen, M. Sehested, P. B. Jensen, 1994, Cancer research.

Continuous recording of long-chain acyl-coenzyme a synthetase activity using fluorescently labeled bovine serum albumin.

E. Demant, B. Nystrøm, 2001, Analytical biochemistry.

Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity

H. Hansen, I. Christensen, M. Sehested, 2004, Cancer Chemotherapy and Pharmacology.

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

H. Hansen, M. Sehested, P. B. Jensen, 1989, British Journal of Cancer.

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.

M. Sehested, P. B. Jensen, N. Bindslev, 1989, British Journal of Cancer.

Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin.

E. Demant, 1991, Biochemical pharmacology.

Doxorubicin induced alterations in lipid metabolism of cultured myocardial cells.

K. Wassermann, E. Demant, 1985, Biochemical pharmacology.

Binding of adriamycin-Fe3+ complex to membrane phospholipids.

E. Demant, 1984, European journal of biochemistry.

Destruction of phospholipids and respiratory-chain activity in pig-heart submitochondrial particles induced by an adriamycin-iron complex.

P. K. Jensen, E. Demant, 1983, European journal of biochemistry.

NADH oxidation in submitochondrial particles protects respiratory chain activity against damage by adriamycin-Fe3+.

E. Demant, 1983, European journal of biochemistry.

Recognition of anthracycline binding domains in bovine serum albumin and design of a free fatty acid sensor protein.

M. Sehested, E. Demant, 1993, Biochimica et biophysica acta.

Characterization of the cooperative cross-linking of doxorubicin N-hydroxysuccinimide ester derivatives to water soluble proteins.

M. Sehested, P. B. Jensen, E. Demant, 1991, Biochimica et biophysica acta.

Bovine serum albumin-(7-hydroxycoumarin-4-acetic acid) complex: applications to the fluorometric measurement of fatty acid concentrations.

E. Demant, 1999, Analytical biochemistry.

Enzyme-linked immunosorbent assay for determination of anti-mitochondrial antibodies.

H. Permin, E. Demant, S. Mouritsen, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.

H. Hansen, M. Sehested, P. B. Jensen, 1990, Cancer research.

Mobilization of ferritin-iron by the anticancer agent bleomycin.

P. Ebbesen, N. nørskov-lauritsen, E. Demant, 1987, Biochemical pharmacology.

High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.

A. Wiik, H. Permin, E. Demant, 1986, Clinical and experimental immunology.

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II.

H. Hansen, M. Sehested, K. Wassermann, 1991, Cancer research.

Relationship of VP-16 to the Classical Multidrug Resistance Phenotype1

M. Sehested, P. B. Jensen, E. Demant, 2006 .

Localization of phospholipids in the membrane of Bacillus megaterium.

L. van Deenen, E. Demant, J. Op den Kamp, 1979, European journal of biochemistry.

Visualization of lipid biosynthesis in isolated cytoplasmic membrane vesicles of Escherichia coli by freeze fracture electron microscopy.

E. Demant, J. Op den Kamp, 1982, Archives of biochemistry and biophysics.

Incorporation of large quantities of phospholipid by net de novo synthesis in cytoplasmic membrane vesicles of Escherichia coli.

E. Demant, 1981, Biochimica et biophysica acta.

Fatty acid inhibition of triacylglycerol lipase in mitochondrial fractions from baker's yeast

E. Demant, 1978, FEBS letters.

A stable triacylglycerol emulsion for assay of soluble and membrane associated lipolytic activity.

E. Demant, 1977, Biochimica et biophysica acta.

Equilibrium binding of anthracycline cytostatics to serum albumin and small unilamellar phospholipid vesicles as measured by gel filtration.

E. Demant, E. Friche, 1998, Biochemical pharmacology.

Transfer of ferritin‐bound iron to adriamycin

E. Demant, Erland J.F. Demant, 1984, FEBS letters.

Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.

M. Sehested, N. Nissen, E. Demant, 1993, British Journal of Cancer.

Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding.

E. Demant, E. Friche, 1998, Biochemical pharmacology.

Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16).

M. Sehested, P. B. Jensen, E. Demant, 1993, Biochemical pharmacology.

Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

R. Pieters, K. Sikora, W. Siegert, 1991, Journal of Cancer Research and Clinical Oncology.

Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.

H. Hansen, M. Sehested, E. Kjeldsen, 1993, Biochemical pharmacology.

The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.

M. Sehested, P. B. Jensen, N. Nissen, 1990, Cancer communications.

Kinetics of phosphatidylglycerol synthesis in isolated membrane vesicles from Escherichia coli containing different amounts of membrane-bound phosphatidic acid.

E. Demant, 1982, European journal of biochemistry.

Covalent modification of serum transferrin with phospholipid and incorporation into liposomal membranes.

G. Hansen, E. Demant, P. B. Jensen, 1989, Biochimica et biophysica acta.

Covalent complexes between serum albumin and 7-hydroxycoumarin-4-acetic acid: synthesis and applications in the spectrophotometric detection of long-chain fatty acids.

E. Demant, 1996, Biochimica et biophysica acta.

Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.

M. Sehested, P. B. Jensen, N. Bindslev, 1990, British Journal of Cancer.

A procedure for removal of interfering phospholipids in the separation and analysis of proteins.

E. Demant, K. Christiansen, J. Carlsen, 1985, Analytical biochemistry.

The human placental transferrin receptor: Reconstitution into liposomes and electron microscopy

J. Tranum-Jensen, E. Demant, K. Christiansen, 1992, Bioscience reports.